Immune cell regulation by autocrine purinergic signalling

被引:632
作者
Junger, Wolfgang G. [1 ,2 ]
机构
[1] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg, Boston, MA 02215 USA
[2] Ludwig Boltzmann Inst Traumatol, A-1200 Vienna, Austria
基金
美国国家卫生研究院;
关键词
EXTRACELLULAR ADENOSINE-TRIPHOSPHATE; NUCLEOSIDE TRANSPORTER FAMILY; FIND-ME SIGNAL; ATP RELEASE; NEUTROPHIL CHEMOTAXIS; RECEPTOR ANTAGONISTS; ADENINE-NUCLEOTIDES; EXTRAENZYMATIC ROLE; INDUCE CHEMOTAXIS; P2Y(6) RECEPTORS;
D O I
10.1038/nri2938
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Stimulation of almost all mammalian cell types leads to the release of cellular ATP and autocrine feedback through a diverse array of purinergic receptors. Depending on the types of purinergic receptors that are involved, autocrine signalling can promote or inhibit cell activation and fine-tune functional responses. Recent work has shown that autocrine signalling is an important checkpoint in immune cell activation and allows immune cells to adjust their functional responses based on the extracellular cues provided by their environment. This Review focuses on the roles of autocrine purinergic signalling in the regulation of both innate and adaptive immune responses and discusses the potential of targeting purinergic receptors for treating immune-mediated disease.
引用
收藏
页码:201 / 212
页数:12
相关论文
共 126 条
  • [1] International union of pharmacology LVIII: Update on the P2Y G protein-coupled nucleotide receptors: From molecular mechanisms and pathophysiology to therapy
    Abbracchio, Maria P.
    Burnstock, Geoffrey
    Boeynaems, Jean-Marie
    Barnard, Eric A.
    Boyer, Jose L.
    Kennedy, Charles
    Knight, Gillian E.
    Fumagalli, Marta
    Gachet, Christian
    Jacobson, Kenneth A.
    Weisman, Gary A.
    [J]. PHARMACOLOGICAL REVIEWS, 2006, 58 (03) : 281 - 341
  • [2] Purinergic signalling in the nervous system: an overview
    Abbracchio, Maria P.
    Burnstock, Geoffrey
    Verkhratsky, Alexei
    Zimmermann, Herbert
    [J]. TRENDS IN NEUROSCIENCES, 2009, 32 (01) : 19 - 29
  • [3] The extracellular versus intracellular mechanisms of inhibition of TCR-triggered activation in thymocytes by adenosine under conditions of inhibited adenosine deaminase
    Apasov, SG
    Sitkovsky, MV
    [J]. INTERNATIONAL IMMUNOLOGY, 1999, 11 (02) : 179 - 189
  • [4] Apasov SG, 2001, J CLIN INVEST, V108, P131, DOI 10.1172/JCI10360
  • [5] Baharav E, 2005, J RHEUMATOL, V32, P469
  • [6] The equilibrative nucleoside transporter family, SLC29
    Baldwin, SA
    Beal, PR
    Yao, SYM
    King, AE
    Cass, CE
    Young, JD
    [J]. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2004, 447 (05): : 735 - 743
  • [7] The anti-inflammatory effect of A3 adenosine receptor agonists:: a novel targeted therapy for rheumatoid arthritis
    Bar-Yehuda, Sara
    Silverman, Michael H.
    Kerns, William D.
    Ochaion, Avivit
    Cohen, Shira
    Fishman, Pnina
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (10) : 1601 - 1613
  • [8] Adenosine receptor antagonists: Translating medicinal chemistry and pharmacology into clinical utility
    Baraldi, Pier Giovanni
    Tabrizi, Mojgan Aghazadeh
    Gessi, Stefania
    Borea, Pier Andrea
    [J]. CHEMICAL REVIEWS, 2008, 108 (01) : 238 - 263
  • [9] Deletion of CD39 on Natural Killer Cells Attenuates Hepatic Ischemia/Reperfusion Injury in Mice
    Beldi, Guido
    Banz, Yara
    Kroemer, Alexander
    Sun, Xiaofeng
    Wu, Yan
    Graubardt, Nadine
    Rellstab, Alyssa
    Nowak, Martina
    Enjyoji, Keiichi
    Li, Xian
    Junger, Wolfgang G.
    Candinas, Daniel
    Robson, Simon C.
    [J]. HEPATOLOGY, 2010, 51 (05) : 1702 - 1711
  • [10] Concomitant activation of P2Y2 and P2Y6 receptors on monocytes is required for TLR1/2-induced neutrophil migration by regulating IL-8 secretion
    Ben Yebdri, Fethia
    Kukulski, Filip
    Tremblay, Alain
    Sevigny, Jean
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2009, 39 (10) : 2885 - 2894